152 related articles for article (PubMed ID: 34932152)
1. Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway.
Johnstone MS; Burton P; Kourounis G; Winter J; Crighton E; Mansouri D; Witherspoon P; Smith K; McSorley ST
Int J Colorectal Dis; 2022 Feb; 37(2):457-466. PubMed ID: 34932152
[TBL] [Abstract][Full Text] [Related]
2. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of a quantitative faecal immunochemical test vs. symptoms suspected for colorectal cancer in patients referred for colonoscopy.
Tsapournas G; Hellström PM; Cao Y; Olsson LI
Scand J Gastroenterol; 2020 Feb; 55(2):184-192. PubMed ID: 31906738
[No Abstract] [Full Text] [Related]
4. Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care.
Mowat C; Digby J; Strachan JA; McCann RK; Carey FA; Fraser CG; Steele RJ
Ann Clin Biochem; 2021 May; 58(3):211-219. PubMed ID: 33334134
[TBL] [Abstract][Full Text] [Related]
5. Using the faecal immunochemical test in patients with rectal bleeding: evidence from the NICE FIT study.
Hicks G; D'Souza N; Georgiou Delisle T; Chen M; Benton SC; Abulafi M;
Colorectal Dis; 2021 Jul; 23(7):1630-1638. PubMed ID: 33605522
[TBL] [Abstract][Full Text] [Related]
6. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
[TBL] [Abstract][Full Text] [Related]
7. Do risk scores improve use of faecal immunochemical testing for haemoglobin in symptomatic patients in primary care?
Digby J; Fraser CG; Clark G; Mowat C; Strachan JA; Steele RJC
Colorectal Dis; 2024 Apr; 26(4):675-683. PubMed ID: 38424669
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care.
Johnstone MS; MacLeod C; Digby J; Al-Azzawi Y; Pang G; Watson AJM; Strachan J; Mowat C; McSorley ST
Colorectal Dis; 2022 Dec; 24(12):1498-1504. PubMed ID: 35776684
[TBL] [Abstract][Full Text] [Related]
9. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysis.
Westwood M; Corro Ramos I; Lang S; Luyendijk M; Zaim R; Stirk L; Al M; Armstrong N; Kleijnen J
Health Technol Assess; 2017 May; 21(33):1-234. PubMed ID: 28643629
[TBL] [Abstract][Full Text] [Related]
10. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
Chapman CJ; Banerjea A; Humes DJ; Allen J; Oliver S; Ford A; Hardy K; Djedovic N; Logan RF; Morling JR
Clin Chem Lab Med; 2021 Mar; 59(4):721-728. PubMed ID: 33112776
[TBL] [Abstract][Full Text] [Related]
11. Introduction of an integrated primary care faecal immunochemical test referral pathway for patients with suspected colorectal cancer symptoms.
Georgiou Delisle T; D'Souza N; Tan J; Najdawi A; Chen M; Ward H; Abulafi M
Colorectal Dis; 2022 Dec; 24(12):1526-1534. PubMed ID: 35934985
[TBL] [Abstract][Full Text] [Related]
12. Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community-based cohort study.
Pin-Vieito N; García Nimo L; Bujanda L; Román Alonso B; Gutierrez-Stampa MÁ; Aguilar-Gama V; Portillo I; Cubiella J
United European Gastroenterol J; 2021 Mar; 9(2):256-267. PubMed ID: 32778002
[TBL] [Abstract][Full Text] [Related]
13. High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis.
Pin Vieito N; Zarraquiños S; Cubiella J
World J Gastroenterol; 2019 May; 25(19):2383-2401. PubMed ID: 31148909
[TBL] [Abstract][Full Text] [Related]
14. Early clinical outcomes of a rapid colorectal cancer diagnosis pathway using faecal immunochemical testing in Nottingham.
Chapman C; Thomas C; Morling J; Tangri A; Oliver S; Simpson JA; Humes DJ; Banerjea A
Colorectal Dis; 2020 Jun; 22(6):679-688. PubMed ID: 31876975
[TBL] [Abstract][Full Text] [Related]
15. Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a diagnostic accuracy study.
D'Souza N; Georgiou Delisle T; Chen M; Benton S; Abulafi M;
Gut; 2021 Jun; 70(6):1130-1138. PubMed ID: 33087488
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic accuracy of the faecal immunohistochemical test in identifying significant bowel disease in a symptomatic population.
MacDonald S; MacDonald L; Godwin J; Macdonald A; Thornton M
Colorectal Dis; 2022 Mar; 24(3):257-263. PubMed ID: 34797583
[TBL] [Abstract][Full Text] [Related]
17. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
[TBL] [Abstract][Full Text] [Related]
18. Understanding colorectal cancer risk for symptomatic patients in primary care: A cohort study utilising faecal immunochemical tests and blood results in England.
Crooks CJ; Banerjea A; Jones J; Chapman C; Oliver S; West J; Humes DJ
Aliment Pharmacol Ther; 2023 Aug; 58(4):443-452. PubMed ID: 37421214
[TBL] [Abstract][Full Text] [Related]
19. Measurement of faecal haemoglobin with a faecal immunochemical test can assist in defining which patients attending primary care with rectal bleeding require urgent referral.
Digby J; Strachan JA; McCann R; Steele RJ; Fraser CG; Mowat C
Ann Clin Biochem; 2020 Jul; 57(4):325-327. PubMed ID: 32482080
[TBL] [Abstract][Full Text] [Related]
20. Quantitative FIT stratification is superior to NICE referral criteria NG12 in a high-risk colorectal cancer population.
Bailey JA; Ibrahim H; Bunce J; Chapman CJ; Morling JR; Simpson JA; Humes DJ; Banerjea A
Tech Coloproctol; 2021 Oct; 25(10):1151-1154. PubMed ID: 34263362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]